Tag Archives: Merck

Exosome Diagnostics Enters Agreement with Merck

exosome rna

Exosome Diagnostics, Inc. has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to help further the company’s drug development efforts in oncology and other therapeutic areas, utilizing the full breadth of Exosome Diagnostics’ ...

Read More »